We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$31M
Cap. Flow
+$23.6M
Cap. Flow %
22.35%
Top 10 Hldgs %
37.42%
Holding
105
New
22
Increased
35
Reduced
19
Closed
22

Top Buys

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$6.61M
2
AGN.PRA
Allergan plc
AGN.PRA
+$1.98M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$1.72M
4
CNC icon
Centene
CNC
+$1.44M
5
JD icon
JD.com
JD
+$1.26M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$4.01M
2
UHS icon
Universal Health Services
UHS
+$1.84M
3
PCRX icon
Pacira BioSciences
PCRX
+$1.72M
4
MCK icon
McKesson
MCK
+$1.63M
5
BABA icon
Alibaba
BABA
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 34.37%
2 Technology 14.09%
3 Communication Services 5.97%
4 Consumer Discretionary 5.14%
5 Financials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BABA icon
26
Alibaba
BABA
$305B
$1.46M 1.39%
8,473
-7,068
-45% -$1.15M
NOW icon
27
ServiceNow
NOW
$118B
$1.44M 1.37%
61,450
-6,900
-10% -$153K
ACOR
28
DELISTED
Acorda Therapeutics
ACOR
$1.42M 1.34%
499
+101
+25% +$266K
UNH icon
29
UnitedHealth
UNH
$377B
$1.32M 1.26%
6,761
-660
-9% -$128K
BOX icon
30
Box
BOX
$4.39B
$1.31M 1.24%
67,578
+39,867
+144% +$749K
CNC icon
31
CALL
Centene
CNC
$31.5B
$1.3M 1.23%
+26,800
New +$1.15M
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$1.21M 1.15%
+4,832
New +$1.19M
NFLX icon
33
Netflix
NFLX
$305B
$1.16M 1.1%
+63,830
New +$1.11M
PYPL icon
34
PayPal
PYPL
$49.5B
$1.13M 1.07%
17,606
+9,308
+112% +$558K
PFE icon
35
Pfizer
PFE
$143B
$1.11M 1.05%
+32,738
New +$1.05M
MDCO
36
DELISTED
Medicines Co
MDCO
$1.09M 1.03%
29,439
-6,281
-18% -$232K
HUM icon
37
Humana
HUM
$45B
$1.09M 1.03%
4,461
-3,130
-41% -$767K
MOH icon
38
Molina Healthcare
MOH
$10.2B
$976K 0.93%
14,197
-4,096
-22% -$267K
MYOK
39
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$974K 0.92%
22,737
-4,633
-17% -$148K
DXC icon
40
DXC Technology
DXC
$1.75B
$943K 0.89%
12,696
-7,274
-36% -$516K
XBI icon
41
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$934K 0.89%
+10,792
New +$865K
PANW icon
42
Palo Alto Networks
PANW
$283B
$911K 0.86%
37,944
– –
META icon
43
CALL
Meta Platforms (Facebook)
META
$1.5T
$906K 0.86%
+5,300
New +$884K
JUNO
44
DELISTED
Juno Therapeutics, Inc.
JUNO
$889K 0.84%
+19,808
New +$675K
PEN icon
45
Penumbra
PEN
$12.7B
$867K 0.82%
9,603
+1,727
+22% +$149K
RVTY icon
46
Revvity
RVTY
$12.9B
$841K 0.8%
12,198
+572
+5% +$38.4K
SPGI icon
47
S&P Global
SPGI
$123B
$819K 0.78%
5,237
-477
-8% -$72.5K
NTES icon
48
NetEase
NTES
$84.2B
$800K 0.76%
15,160
+4,145
+38% +$238K
INCY icon
49
PUT
Incyte
INCY
$24B
$770K 0.73%
+6,600
New +$835K
ZEN
50
DELISTED
ZENDESK INC
ZEN
$679K 0.64%
23,323
+11,069
+90% +$311K
1
2
3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Partner Investment Management held 105 positions worth $105M, up 42% from $74.4M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Partner Investment Management deployed $23.6M of net new capital in Q3 2017, opening 22 new positions and adding to 35 existing holdings. Its largest new stake was Sienna Biopharmaceuticals, Inc.: 300,940 shares worth $6.7M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $4.01M trimmed.

  • Partner Investment Management's largest Q3 2017 buy was Sienna Biopharmaceuticals, Inc.: 300,940 shares worth $6.7M.
  • Partner Investment Management added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $1.72M increase.
  • Partner Investment Management's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $4.01M.
  • Partner Investment Management fully exited Universal Health Services in Q3 2017, selling an estimated $1.84M.
  • Partner Investment Management's ten largest holdings make up 37% of its $105M portfolio in Q3 2017.
  • Partner Investment Management opened 22 new positions and closed 22 in Q3 2017.
  • Partner Investment Management's portfolio value rose 42% quarter-over-quarter to $105M.

Based on Partner Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.